Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNGX Soligenix, Inc.

交易中 02-26 14:10:23 EST

1.15

-0.03

-2.54%

最高1.22	最低1.13	成交量38.79万
今开1.16	昨收1.18	日振幅7.61%
总市值1,160万	流通市值911.82万	总股本1,009万
成交额45.72万	换手率4.89%	流通股本792.89万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNGX","market":"US","secType":"STK","nameCN":"Soligenix, Inc.","latestPrice":1.15,"timestamp":1772133018833,"preClose":1.18,"halted":0,"volume":387886,"delay":0,"changeRate":-0.025423728813559344,"floatShares":7928900,"shares":10086130,"eps":-3.389437,"marketStatus":"交易中","change":-0.03,"latestTime":"02-26 14:10:23 EST","open":1.16,"high":1.22,"low":1.1302,"amount":457164.1462984,"amplitude":0.076102,"askPrice":1.16,"askSize":300,"bidPrice":1.13,"bidSize":240,"shortable":3,"etf":0,"ttmEps":-3.389437,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772139600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.18,"preHourTrading":{"tag":"盘前","latestPrice":1.15,"preClose":1.18,"latestTime":"09:23 EST","volume":94988,"amount":118266.16772839999,"timestamp":1772115785007,"change":-0.03,"changeRate":-0.025424,"amplitude":0.118644},"postHourTrading":{"tag":"盘后","latestPrice":1.15,"preClose":1.18,"latestTime":"19:48 EST","volume":591,"amount":681.6238,"timestamp":1772066883888,"change":-0.03,"changeRate":-0.025424,"amplitude":0.025424},"volumeRatio":6.477385},"requestUrl":"/m/hq/s/SNGX/tweets","defaultTab":"tweets","newsList":[{"id":"1127152482","title":"Soligenix获欧洲药品管理局支持 SGX945治疗白塞病获孤儿药资格认定积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1127152482","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127152482?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:35","pubTimestamp":1772109315,"startTime":"0","endTime":"0","summary":"生物制药公司Soligenix, Inc.近日宣布，其研发的SGX945用于治疗白塞病（Behçet's Disease）的孤儿药资格认定申请，已获得欧洲药品管理局（EMA）的积极评价。\n这一重要进展意味着SGX945在针对这一罕见炎症性疾病的开发进程中迈出了关键一步。孤儿药资格认定旨在鼓励针对罕见疾病的药物研发，通常能为企业带来包括市场独占期在内的多项政策利好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"1177202015","title":"Soligenix持续评估潜在战略选项，涵盖合作及并购机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1177202015","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177202015?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:37","pubTimestamp":1770899829,"startTime":"0","endTime":"0","summary":"Soligenix, Inc. 近日透露，公司正在持续对其潜在的战略选项进行全面评估。这些战略方向广泛，不仅限于寻求合作伙伴关系，还包括探索各类并购机会。此举表明该公司正积极谋划未来发展路径，以增强企业竞争力和市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"1186113387","title":"Sgx945治疗贝赫切特病的二期临床试验积极结果发表在《牛津风湿病学》","url":"https://stock-news.laohu8.com/highlight/detail?id=1186113387","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186113387?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:33","pubTimestamp":1766061210,"startTime":"0","endTime":"0","summary":"Sgx945治疗贝赫切特病的二期临床试验积极结果发表在《牛津风湿病学》","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"1110318372","title":"Soligenix公布SGX302二期A期研究的关键结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1110318372","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110318372?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:11","pubTimestamp":1765977097,"startTime":"0","endTime":"0","summary":"12月17日 - Soligenix Inc :: *Soligenix公布SGX302（合成高超越素）在轻度至中度牛皮癣患者中的二期A期研究的关键结果*Soligenix Inc - 优化的凝胶配方在第三组显示出成功*Soligenix Inc - SGX302凝胶疗法耐受性良好且无不良事件*Soligenix Inc - 研究确认SGX302改善牛皮癣病灶 ((投资者简报; 电子邮件: reutersinvestor.briefs@thomsonreuters.com)) 来源日期/时间 = 2025年12月17日12:30:00.08 GMT","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"1145439786","title":"Soligenix公布Sgx302（合成高光素）在中度至轻度银屑病患者中的Ⅱa期研究总体结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1145439786","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145439786?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:35","pubTimestamp":1765974916,"startTime":"0","endTime":"0","summary":"Soligenix公布Sgx302（合成高光素）在中度至轻度银屑病患者中的Ⅱa期研究总体结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"1115608124","title":"Soligenix达成Enrollment里程碑，计划进行Hybryte™治疗皮肤T细胞淋巴瘤的确认性第三阶段临床试验中期分析","url":"https://stock-news.laohu8.com/highlight/detail?id=1115608124","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115608124?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:31","pubTimestamp":1763555471,"startTime":"0","endTime":"0","summary":"Soligenix达成Enrollment里程碑，计划进行Hybryte™治疗皮肤T细胞淋巴瘤的确认性第三阶段临床试验中期分析","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"1117463852","title":"Soligenix, Inc.在Hybryte™治疗皮肤T细胞淋巴瘤的确认性3期临床试验中取得重要安全里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1117463852","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117463852?lang=zh_cn&edition=full","pubTime":"2025-10-07 19:31","pubTimestamp":1759836699,"startTime":"0","endTime":"0","summary":"Soligenix, Inc.在其针对皮肤T细胞淋巴瘤治疗药物Hybryte™的确认性3期临床试验中达成了重要的安全性里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"1134174442","title":"Soligenix宣布任命前白宫经济顾问Tomas J. Philipson博士为战略顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=1134174442","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134174442?lang=zh_cn&edition=full","pubTime":"2025-09-23 19:31","pubTimestamp":1758627075,"startTime":"0","endTime":"0","summary":"Soligenix宣布任命前白宫经济顾问Tomas J. Philipson博士为战略顾问。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"1155726677","title":"Soligenix公司宣布发表埃博拉及相关病毒蛋白亚单位疫苗长期高温稳定性研究论文","url":"https://stock-news.laohu8.com/highlight/detail?id=1155726677","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155726677?lang=zh_cn&edition=full","pubTime":"2025-09-04 19:30","pubTimestamp":1756985439,"startTime":"0","endTime":"0","summary":"Soligenix公司宣布发表埃博拉及相关病毒蛋白亚单位疫苗长期高温稳定性研究论文","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2511612939","title":"Soligenix, Inc.盘中异动 股价大跌6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511612939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511612939?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:36","pubTimestamp":1739565390,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时36分，Soligenix, Inc.股票出现波动，股价大幅跳水6.10%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3195.82%、818.69%、638.68%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为74.35%、71.65%、66.45%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215043630abcf5375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215043630abcf5375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2511574394","title":"Soligenix, Inc.盘中异动 快速上涨5.22%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511574394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511574394?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:58","pubTimestamp":1739476680,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时58分，Soligenix, Inc.股票出现波动，股价快速拉升5.22%。截至发稿，该股报2.42美元/股，成交量1.931万股，换手率0.77%，振幅4.17%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Moleculin Biotech, Inc.、Dominari Holdings Inc.、Edesa Biotech, Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3228.75%、2127.47%、1245.15%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021403580098846af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021403580098846af8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2508212344","title":"Soligenix, Inc.盘中异动 股价大跌5.15%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508212344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508212344?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:04","pubTimestamp":1738602274,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时04分，Soligenix, Inc.股票出现异动，股价快速下挫5.15%。截至发稿，该股报2.21美元/股，成交量3.0778万股，换手率1.23%，振幅4.29%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为652.11%、451.66%、395.03%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、75.23%、63.94%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010434987984ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010434987984ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2507622260","title":"Soligenix, Inc.盘中异动 股价大跌5.99%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507622260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507622260?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:16","pubTimestamp":1738250189,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时16分，Soligenix, Inc.股票出现异动，股价急速下挫5.99%。截至发稿，该股报2.28美元/股，成交量5061股，换手率0.20%，振幅2.48%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1413.79%、178.61%、177.43%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited、Kazia Therapeutics Limited，振幅分别为56.41%、52.92%、42.03%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231630961442da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231630961442da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2506584953","title":"Soligenix, Inc.盘中异动 股价大跌5.08%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506584953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506584953?lang=zh_cn&edition=full","pubTime":"2025-01-28 04:27","pubTimestamp":1738009626,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日04时27分，Soligenix, Inc.股票出现波动，股价快速跳水5.08%。截至发稿，该股报2.43美元/股，成交量3.6432万股，换手率1.45%，振幅5.66%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2199.67%、1101.78%、270.93%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.60%、99.77%、65.16%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804270696126c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804270696126c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2505930010","title":"Soligenix, Inc.盘中异动 早盘急速跳水5.28%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505930010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505930010?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:15","pubTimestamp":1737645345,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时15分，Soligenix, Inc.股票出现异动，股价急速下跌5.28%。截至发稿，该股报2.33美元/股，成交量8342股，换手率0.33%，振幅4.47%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Hepion Pharmaceuticals, Inc.、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3062.99%、600.16%、59.65%，振幅较大的相关个股有Jupiter Neurosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts ，振幅分别为55.57%、54.22%、49.73%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123231545a22d12da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123231545a22d12da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2505726090","title":"Soligenix, Inc.盘中异动 股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505726090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505726090?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:33","pubTimestamp":1737556437,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时33分，Soligenix, Inc.股票出现波动，股价急速拉升6.25%。截至发稿，该股报2.55美元/股，成交量6954股，换手率0.28%，振幅0.00%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Immunoprecise Antibodies Ltd.、Nutriband Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为463.92%、96.45%、53.77%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Nutriband Inc.、Genelux Corporation，振幅分别为27.53%、17.27%、14.89%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223357986f7808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223357986f7808&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2505470271","title":"Soligenix, Inc.盘中异动 快速下跌5.05%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505470271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505470271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:45","pubTimestamp":1737470705,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时45分，Soligenix, Inc.股票出现异动，股价快速下跌5.05%。截至发稿，该股报2.23美元/股，成交量1.6452万股，换手率0.66%，振幅5.90%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Channel Therapeutics Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Replimune Group, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为595.36%、164.28%、50.30%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Atara Biotherapeutics, Inc.，振幅分别为73.16%、38.48%、17.50%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224506a22a5a13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224506a22a5a13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2504173301","title":"Soligenix, Inc.盘中异动 股价大涨5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504173301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504173301?lang=zh_cn&edition=full","pubTime":"2025-01-18 03:11","pubTimestamp":1737141082,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日03时11分，Soligenix, Inc.股票出现波动，股价大幅上涨5.29%。截至发稿，该股报2.39美元/股，成交量7.9239万股，换手率3.16%，振幅7.49%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118031122986a4ef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118031122986a4ef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2504944289","title":"Soligenix, Inc.盘中异动 大幅拉升5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504944289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504944289?lang=zh_cn&edition=full","pubTime":"2025-01-17 03:40","pubTimestamp":1737056450,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日03时40分，Soligenix, Inc.股票出现波动，股价快速拉升5.29%。截至发稿，该股报2.39美元/股，成交量14.4033万股，换手率5.74%，振幅7.49%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117034050a224a216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117034050a224a216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2503640448","title":"Soligenix, Inc.股价重挫11.78% 市值跌69.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503640448?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:35","pubTimestamp":1736951701,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时35分，Soligenix, Inc.股票出现异动，股价急速跳水11.78%。截至发稿，该股报2.32美元/股，成交量15.1947万股，换手率6.05%，振幅5.70%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Exicure, Inc.、Monte Rosa Therapeutics, Inc.、Lexaria Bioscience Corp.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为187.51%、60.81%、35.82%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522350198673c15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522350198673c15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.soligenix.com","stockEarnings":[{"period":"1week","weight":0.0826},{"period":"1month","weight":-0.0853},{"period":"3month","weight":-0.1973},{"period":"6month","weight":-0.6194},{"period":"1year","weight":-0.4779},{"period":"ytd","weight":-0.1194}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Soligenix, Inc.成立于1987年，是一家临床阶段生物制药公司，专注于开发产品，治疗癌症和严重的胃肠道疾病的治疗所产生的危及生命的副作用（仍然是一个未满足的医疗需求），以及开发多种生物防御疫苗和疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.084195},{"month":2,"riseRate":0.5,"avgChangeRate":-0.039075},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.092364},{"month":4,"riseRate":0.111111,"avgChangeRate":-0.1421},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.118269},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.120983},{"month":7,"riseRate":0.777778,"avgChangeRate":0.373996},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.061062},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.065432},{"month":10,"riseRate":0.222222,"avgChangeRate":0.004798},{"month":11,"riseRate":0.555556,"avgChangeRate":0.121738},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.126538}],"exchange":"NASDAQ","name":"Soligenix, Inc.","nameEN":"Soligenix, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Soligenix, Inc.(SNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Soligenix, Inc.,SNGX,Soligenix, Inc.股票,Soligenix, Inc.股票老虎,Soligenix, Inc.股票老虎国际,Soligenix, Inc.行情,Soligenix, Inc.股票行情,Soligenix, Inc.股价,Soligenix, Inc.股市,Soligenix, Inc.股票价格,Soligenix, Inc.股票交易,Soligenix, Inc.股票购买,Soligenix, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Soligenix, Inc.(SNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}